LATEST
Cencora agreed to acquire American Oncology NetworknewAPEX / KorainewSmith & Wesson Brands agreed to acquire Long Range IntermediatenewBose acquired SkullcandyMaximus Federal Services agreed to acquire Agile DefenseMount Logan Management agreed to acquire Alternative Fund AdvisorsDime Commercial Bancshares / ES BancsharesSalesforce agreed to acquire BrazeJV Investors / Oro Mobility HoldingsMorgan Stanley Capital Partners acquired The Rapid GroupCBRE Group agreed to acquire Onnec GroupBevPoint Capital agreed to acquire ESG
Open App
Agreement signedPublished 10 Nov 2022

Royalty Pharma Investments 2019 ICAV /
Arrowhead Pharmaceuticals, Inc.

Royalty Pharma to purchase Arrowhead royalty interest

Price
$410m
Stage
Agreement signed
Buy side: Royalty Pharma Investments 2019 ICAV
Buy sideRoyalty Pharma Investments 2019 ICAV
Target: Arrowhead Pharmaceuticals, Inc.
TargetArrowhead Pharmaceuticals, Inc.
Source · 10 Nov 2022
See the source
Buy side: Royalty Pharma Investments 2019 ICAV
Buy sideRoyalty Pharma Investments 2019 ICAV
Target: Arrowhead Pharmaceuticals, Inc.
TargetArrowhead Pharmaceuticals, Inc.
01 / BuyerRoyalty Pharma Investments 2019 ICAV
02 / TargetArrowhead Pharmaceuticals, Inc.
01

What happened

Royalty Pharma Investments 2019 ICAV agreed to pay Arrowhead Pharmaceuticals, Inc. up to $410 million in cash for its future royalty interest in Olpasiran.

The arrangement includes $250 million upfront and up to $160 million in milestone payments.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Royalty Pharma to purchase Arrowhead royalty interest

This document is the source for the companies, stage, figure and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.